- $15.23m
- $15.36m
- $5.20m
- 29
- 24
- 49
- 25
Annual balance sheet for Zeo Scientifix, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2021 October 31st | 2022 October 31st | R2023 October 31st | 2024 October 31st | 2025 October 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.109 | 3.75 | 1.76 | 0.657 | 0.221 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.104 | 0.191 | 0.03 | 0.197 | 0.035 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.517 | 4.37 | 2.2 | 1.17 | 0.958 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.37 | 1.79 | 0.573 | 0.478 | 0.569 |
| Other Long Term Assets | |||||
| Total Assets | 1.93 | 6.2 | 2.78 | 1.64 | 1.53 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.13 | 4.06 | 4.01 | 3.29 | 2.87 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.6 | 4.31 | 4.02 | 3.3 | 2.95 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -2.67 | 1.89 | -1.24 | -1.65 | -1.42 |
| Total Liabilities & Shareholders' Equity | 1.93 | 6.2 | 2.78 | 1.64 | 1.53 |
| Total Common Shares Outstanding |